DaVita (DVA) Tops Q4 EPS by 20c, Revenues Miss; Raises FY20 EPS Guidance, Offers FY20 Revenue Outlook
Get Alerts DVA Hot Sheet
Price: $234.91 +3.02%
EPS Growth %: +30.2%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
CRMT, More
EPS Growth %: +30.2%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
DaVita (NYSE: DVA) reported Q4 EPS of $1.86, $0.20 better than the analyst estimate of $1.66. Revenue for the quarter came in at $2.9 billion versus the consensus estimate of $2.92 billion.
Fourth quarter 2019 highlights:
- Consolidated revenues of $2.899 billion.
- Operating income of $463 million or 16.0% operating margin.
- Diluted earnings per share from continuing operations of $1.86.
- Operating cash flow from continuing operations of $678 million and free cash flow from continuing operations of $415 million.
- Repurchased 8,368,506 shares of our common stock at an average cost of $64.80 per share.
GUIDANCE:
DaVita sees FY2020 EPS of $5.75-$6.25, versus the consensus of $5.57. DaVita sees FY2020 revenue of $11.5-11.7 billion, versus the consensus of $11.56 billion.
For earnings history and earnings-related data on DaVita (DVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
- Lucid reports Q2 output, names new CFO and five other leaders
Create E-mail Alert Related Categories
Corporate News, Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share